These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34048504)

  • 1. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
    Murphy SC; Deye GA; Sim BKL; Galbiati S; Kennedy JK; Cohen KW; Chakravarty S; Kc N; Abebe Y; James ER; Kublin JG; Hoffman SL; Richie TL; Jackson LA
    PLoS Pathog; 2021 May; 17(5):e1009594. PubMed ID: 34048504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
    Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
    Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
    Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.
    Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG
    Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity.
    Mwakingwe-Omari A; Healy SA; Lane J; Cook DM; Kalhori S; Wyatt C; Kolluri A; Marte-Salcedo O; Imeru A; Nason M; Ding LK; Decederfelt H; Duan J; Neal J; Raiten J; Lee G; Hume JCC; Jeon JE; Ikpeama I; Kc N; Chakravarty S; Murshedkar T; Church LWP; Manoj A; Gunasekera A; Anderson C; Murphy SC; March S; Bhatia SN; James ER; Billingsley PF; Sim BKL; Richie TL; Zaidi I; Hoffman SL; Duffy PE
    Nature; 2021 Jul; 595(7866):289-294. PubMed ID: 34194041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
    Coulibaly D; Kone AK; Traore K; Niangaly A; Kouriba B; Arama C; Zeguime A; Dolo A; Lyke KE; Plowe CV; Abebe Y; Potter GE; Kennedy JK; Galbiati SM; Nomicos E; Deye GA; Richie TL; James ER; Kc N; Sim BKL; Hoffman SL; Doumbo OK; Thera MA; Laurens MB;
    EClinicalMedicine; 2022 Oct; 52():101579. PubMed ID: 35928033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
    Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
    Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
    Healy SA; Murphy SC; Hume JCC; Shelton L; Kuntz S; Van Voorhis WC; Moodie Z; Metch B; Wang R; Silver-Brace T; Fishbaugher M; Kennedy M; Finney OC; Chaturvedi R; Marcsisin SR; Hobbs CV; Warner-Lubin M; Talley AK; Wong-Madden S; Stuart K; Wald A; Kappe SH; Kublin JG; Duffy PE
    Clin Infect Dis; 2020 Sep; 71(6):1481-1490. PubMed ID: 31621832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
    Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
    Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans.
    Mouwenda YD; Jochems SP; Van Unen V; Betouke Ongwe ME; de Steenhuijsen Piters WA; Stam KA; Massinga Loembe M; Sim BKL; Esen M; Hoffman SL; Kremsner PG; Fendel R; Mordmüller B; Yazdanbakhsh M
    JCI Insight; 2024 May; 9(9):. PubMed ID: 38716733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
    Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
    Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
    Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
    Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
    Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.
    Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW
    Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
    Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
    Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.